Publication | Closed Access

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes

Breast OncologyOncologyMedicinePhase Ii StudyMetastatic Breast CancersBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyPrior Exposure